{
  "actions": [
    {
      "acted_at": "2013-06-11", 
      "committee": "Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-06-11", 
      "committee": "House Energy and Commerce", 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-06-11", 
      "committee": "House Ways and Means", 
      "references": [], 
      "text": "Referred to House Ways and Means", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-06-14", 
      "in_committee": "House Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr2315-113", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "district": "26", 
      "name": "Burgess, Michael C.", 
      "sponsored_at": "2013-06-20", 
      "state": "TX", 
      "thomas_id": "01751", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "7", 
      "name": "Carson, Andre", 
      "sponsored_at": "2013-07-10", 
      "state": "IN", 
      "thomas_id": "01889", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "McKinley, David B.", 
      "sponsored_at": "2013-07-09", 
      "state": "WV", 
      "thomas_id": "02074", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Neal, Richard E.", 
      "sponsored_at": "2013-06-11", 
      "state": "MA", 
      "thomas_id": "00854", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "13", 
      "name": "Schwartz, Allyson Y.", 
      "sponsored_at": "2013-07-10", 
      "state": "PA", 
      "thomas_id": "01798", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "5", 
      "name": "Thompson, Glenn", 
      "sponsored_at": "2013-07-16", 
      "state": "PA", 
      "thomas_id": "01952", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2013-06-11", 
  "number": "2315", 
  "official_title": "To clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s1128-113", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Preserving Access to Orphan Drugs Act of 2013", 
  "sponsor": {
    "district": "6", 
    "name": "Gerlach, Jim", 
    "state": "PA", 
    "thomas_id": "01743", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2013-06-11", 
  "subjects": [
    "Health", 
    "Health care costs and insurance", 
    "Prescription drugs", 
    "User charges and fees"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2013-06-11", 
    "text": "Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. Makes this Act effective as if included in PPACA."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Preserving Access to Orphan Drugs Act of 2013", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-17T16:06:57-04:00"
}